H 2481
An Act prohibiting the sale of dextromethorphan to minors
Take action
Record your position on this measure.
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed House
- Passed Senate
- To Governor
- Became Law
Bill overview
This bill prohibits the sale of dextromethorphan, a common ingredient in over-the-counter cough medications, to individuals under the age of 18. The goal is to reduce potential misuse and associated health risks among minors. The legislation was referred to the Public Health committee and subsequently concurred by the Senate. It is part of a series of similar bills aimed at addressing dextromethorphan access for young people.
Key provisions
- Prohibits the sale of dextromethorphan to individuals under 18.
- Addresses potential misuse of dextromethorphan by minors.
- Targets retail sales of cough medications containing dextromethorphan.
- Requires retailers to verify the age of purchasers.
- Aligns with efforts to promote responsible medication use.
- The bill was referred to the Public Health committee.
- The Senate concurred with the bill.
Who is affected
- Minors (individuals under 18)
- Retailers of over-the-counter medications
- Pharmacies
- Drug stores
- Healthcare providers
Notable changes
- This bill establishes a specific prohibition on dextromethorphan sales to minors, building upon previous legislative efforts.
- It aims to prevent underage access to a substance that can have adverse effects when misused.
Sponsors
Official sponsors from legislative records.
Primary sponsor
David Paul Linsky
Cosponsor
David Paul Linsky
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.
Bill H.2481 194th (Current)
An Act prohibiting the sale of dextromethorphan to minors
By Representative Linsky of Natick, a petition (accompanied by bill, House, No. 2481) of David Paul Linsky relative to prohibiting the sale of dextromethorphan to minors. Public Health.
View Text Print Preview Download PDF
Bill Information
Bill Information
Presenter: David Paul Linsky
Tabs
Bill History Petitioners Committee Vote Committee Summary
Bill History
Displaying 6 actions for Bill H.2481
| Date | Branch | Action |
| 2/27/2025 | House | Referred to the committee on Public Health |
| 2/27/2025 | Senate | Senate concurred |
| 7/3/2025 | Joint | Hearing scheduled for 07/14/2025 from 01:00 PM-05:00 PM in A-1 |
| 7/14/2025 | Joint | Hearing rescheduled to 07/14/2025 from 01:00 PM-06:45 PM in A-1 and Virtual Hearing updated to New End Time |
| 7/14/2025 | Joint | Hearing rescheduled to 07/14/2025 from 01:00 PM-06:05 PM in A-1 and Virtual Hearing updated to New End Time |
| 3/16/2026 | House | Accompanied a study order, see H5234 |
Similar Bills
S.1617 194th (Current)
An Act prohibiting the sale of dextromethorphan to minors
H.1495 191st (2019 - 2020)
An Act prohibiting the sale of dextromethorphan to minors
H.2353 192nd (2021 - 2022)
An Act prohibiting the sale of dextromethorphan to minors
H.2226 193rd (2023 - 2024)
An Act prohibiting the sale of dextromethorphan to minors
S.1456 193rd (2023 - 2024)
An Act prohibiting the sale of dextromethorphan to minors
The information contained in this website is for general information purposes only. The General Court provides this information as a public service and while we endeavor to keep the data accurate and current to the best of our ability, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.